In modern orthopedic, trauma, and craniomaxillofacial surgeries across Greece, achieving reliable osseointegration and mechanical scaffold stability remains a primary clinical benchmark. As a premier global Hydroxyapatite Bone Graft Material Manufacturer & Supplier, Bharucha Associates delivers state-of-the-art synthetic bioactive ceramic bone substitutes to healthcare institutions, private orthopedic clinics, and medical procurement distributors in major Greek metropolitan hubs including Athens, Thessaloniki, Patras, Heraklion, and Larissa.
Synthetic Hydroxyapatite, chemically designated as $Ca_{10}(PO_4)_6(OH)_2$, closely mimics the crystallographic and elemental profile of natural human bone mineral tissue. Operating with an exact stoichiometric Calcium-to-Phosphorus ratio of approximately 1.67, our medical-grade HA implants eliminate all pathogenic transmission risks associated with human allografts or bovine xenografts while establishing an ideal osteoconductive substrate for osteoblast attachment, proliferation, and neo-vascularization.
Features interconnected macropores (100–500 µm) facilitating deep capillary invasion and osteon formation, paired with micropores (<10 µm) optimized for capillary action and bone morphogenetic protein (BMP) adsorption.
Formulated in pure phase HA and custom Biphasic Calcium Phosphate (BCP) ratios (HA/β-TCP 60/40 or 70/30) to align scaffold resorbability perfectly with the natural rate of autologous bone remodeling.
Full regulatory compliance documentation tailored for Greek National Organization for Medicines (EOF) registration and smooth clearance through Greek public hospital ESY tendering protocols.
To provide objective information gain for clinical decision-makers and procurement directors in Greek hospitals, the following evaluation matrix compares synthetic Hydroxyapatite against traditional bone grafting materials across critical surgical and regulatory parameters:
| Performance Metric | Synthetic Hydroxyapatite (HA) | Beta-Tricalcium Phosphate (β-TCP) | Bovine Xenograft | Autologous Bone Graft |
|---|---|---|---|---|
| Chemical Formula | $Ca_{10}(PO_4)_6(OH)_2$ | $Ca_3(PO_4)_2$ | Natural Bovine Hydroxyapatite | Organic ECM + Mineral Base |
| Resorption Rate | Slow & Stable (Years) | Rapid (3 – 6 Months) | Very Slow (Variable) | Natural Remodeling |
| Immunogenicity / Disease Risk | Zero (100% Synthetic) | Zero (100% Synthetic) | Potential Prion / Antigen Risk | Zero (Autogenous) |
| Compressive Strength | High (30 – 130 MPa) | Moderate (5 – 15 MPa) | Moderate (10 – 35 MPa) | Variable by donor site |
| Greek EOF / EU MDR Friction | Minimal (Class III Established) | Minimal (Class III) | High (Tissue Origin Audits) | N/A (Surgical Procedure) |
| Donor Site Morbidity | None | None | None | High (Harvesting Pain) |
The Greek healthcare market operates through a dual ecosystem: the public National Health System (ESY - Εθνικό Σύστημα Υγείας) governed by centralized regional health authorities (YPE), and a burgeoning private clinic sector led by healthcare conglomerates in Attica and Central Macedonia. Public hospital tenders demand strict adherence to price-performance ratios, complete CE certificates under Regulation (EU) 2017/745, and mandatory registration in the EOF electronic database.
Bharucha Associates supports Greek medical importers by supplying fully documented, high-purity Hydroxyapatite granules, porous blocks, injectable bone cements, and complimentary surgical power tools. Our streamlined logistics ensure prompt delivery to major sea and air transport hubs in Piraeus and Thessaloniki.
Orthopedic surgeons across Athens, Patras, and Heraklion utilize our synthetic Hydroxyapatite materials across a wide spectrum of demanding procedures:
Established in 1994 in Vadodara, India, Bharucha Associates has grown into a globally recognized manufacturer, exporter, and total-solution provider of orthopedic medical equipment, battery-operated surgical drills, casting tapes, and synthetic bone graft biomaterials.
Class 10,000 cleanroom synthesis ensuring zero endotoxin risk.
Validated 25 kGy gamma radiation treatment with 5-year shelf life.
Integrated supply of implants, instruments, power tools & graft materials.
Flexible granule pore sizing, block geometry & private labeling.
We supply complete technical dossiers (STED), ISO 13485 quality management audit reports, CE declaration of conformity documents, and material safety testing certificates required by the Greek National Organization for Medicines (EOF) for seamless registration into the National Registry of Medical Devices (GREMD).
We manufacture microporous and macroporous HA in micro-granules (0.25–1.0 mm for dental/periodontal use), macro-granules (1.0–2.0 mm and 2.0–5.0 mm for orthopedic trauma), pre-formed interbody blocks, custom anatomical wedges, and paste-form injectable cements.
Air freight shipments to Athens International Airport (ATH) typically take 3 to 6 business days. Express ocean freight shipments dispatched to the Port of Piraeus or Thessaloniki range between 14 to 22 transit days depending on vessel routing.
Synthetic HA offers 100% lot-to-lot consistency, eliminates immune response concerns, avoids all potential BSE/TSE transmissible spongiform encephalopathy risks, and provides predictable osteoconductive scaffolding during acetabular and femoral reconstruction.
Yes. We offer contract manufacturing, customized blister packaging, localized Greek-language labeling compliance, and custom grain size formulations for OEM distributors and clinic hospital chains across Greece.
As a total solution manufacturer, our bone graft materials work in perfect tandem with our proprietary Manman battery-operated drills, oscillating saws, and specialized total knee and hip replacement placement positioners for frictionless intraoperative execution.
Partner with a globally trusted Hydroxyapatite Bone Graft Material Manufacturer & Supplier. Contact our international export department today to receive sample kits, EOF regulatory packages, and bulk pricing.
